Literature DB >> 29847203

The FDA and the Next Wave of Drug Abuse - Proactive Pharmacovigilance.

Douglas C Throckmorton1, Scott Gottlieb1, Janet Woodcock1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29847203     DOI: 10.1056/NEJMp1806486

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

Authors:  Andrew I Geller; Deborah Dowell; Maribeth C Lovegrove; Jana K McAninch; Sandra K Goring; Kathleen O Rose; Nina J Weidle; Daniel S Budnitz
Journal:  Am J Prev Med       Date:  2019-03-06       Impact factor: 5.043

2.  Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS).

Authors:  Stefania Chiappini; Rachel Vickers-Smith; Amira Guirguis; John M Corkery; Giovanni Martinotti; Daniel R Harris; Fabrizio Schifano
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-27

3.  Using a multi-module web-app to prevent substance use among students at a Hispanic Serving Institution: development and evaluation design.

Authors:  Bethany K W Rainisch; Linn Dahlman; Jorge Vigil; Myriam Forster
Journal:  BMC Public Health       Date:  2022-06-15       Impact factor: 4.135

4.  Association of State-Imposed Restrictions on Gabapentin with Changes in Prescribing in Medicare.

Authors:  Jordan S Grauer; John D Cramer
Journal:  J Gen Intern Med       Date:  2022-01-11       Impact factor: 6.473

5.  Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.

Authors:  Yu-Jung Jenny Wei; Cheng Chen; Siegfried O Schmidt; Wei-Hsuan LoCiganic; Almut G Winterstein
Journal:  Drug Alcohol Depend       Date:  2019-09-27       Impact factor: 4.492

6.  Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification.

Authors:  Michael D Stein; Shannon R Kenney; Bradley J Anderson; Micah T Conti; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2019-12-13

7.  Long-term use of hydrocodone vs. oxycodone in primary care.

Authors:  Rebecca Arden Harris; Henry R Kranzler; Kyong-Mi Chang; Chyke A Doubeni; Robert Gross
Journal:  Drug Alcohol Depend       Date:  2019-11-02       Impact factor: 4.852

8.  Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics.

Authors:  Kirk E Evoy; Chengwen Teng; Victor G Encarnacion; Brian Frescas; John Hakim; Stephen Saklad; Christopher R Frei
Journal:  Subst Abuse       Date:  2019-05-01

9.  Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.

Authors:  Rakshit S Tanna; Dan-Dan Tian; Nadja B Cech; Nicholas H Oberlies; Allan E Rettie; Kenneth E Thummel; Mary F Paine
Journal:  J Pharmacol Exp Ther       Date:  2020-10-22       Impact factor: 4.030

Review 10.  Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network.

Authors:  Thomas Soeiro; Clémence Lacroix; Vincent Pradel; Maryse Lapeyre-Mestre; Joëlle Micallef
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.